SUSAN A BALTZ

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family AMARILLO, TX NPI 1992919484

General Payments — all program years on this page

$4,909.22

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 63
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,593.49 across 14 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,593.4914

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
GlaxoSmithKline, LLC. $250.002
ABBVIE INC. $248.442
Phathom Pharmaceuticals, Inc. $228.013
Acerta Pharma LLC $203.162
Medtronic, Inc. $155.801
Abbott Laboratories $129.531
GENZYME CORPORATION $128.551
Astellas Pharma US Inc $125.001
Novo Nordisk AS $125.001

By program year

Program yearAmountRecords
2021 $1,022.5613
2022 $792.8016
2023 $1,500.3720
2024 $1,593.4914

Records — PY2024 (14)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100653937 Novo Nordisk Inc $125.00 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104429233 AstraZeneca Pharmaceuticals LP $78.16 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105601217 AstraZeneca Pharmaceuticals LP $125.00 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106477944 ABBVIE INC. $123.44 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106477946 ABBVIE INC. $125.00 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116110371 GlaxoSmithKline, LLC. $125.00 10/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116429847 GlaxoSmithKline, LLC. $125.00 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117020158 Medtronic, Inc. $155.80 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1125381028 Abbott Laboratories $129.53 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139524910 Astellas Pharma US Inc $125.00 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139822231 GENZYME CORPORATION $128.55 09/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146942 Phathom Pharmaceuticals, Inc. $52.01 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146944 Phathom Pharmaceuticals, Inc. $125.00 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146946 Phathom Pharmaceuticals, Inc. $51.00 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.